Sildenafil citrate oral films
Sildenafil citrate under various other trade names, is a drug used to treat erectile dysfunction and pulmonary arterial hypertension (PAH). It was originally developed by British scientists and then brought to market by the US-based pharmaceutical company. It acts by inhibiting cGMP-specific phosphodiesterase type 5, an enzyme that promotes degradation of cGMP. Since becoming available in 1998, sildenafil has been the prime treatment for erectile dysfunction; its primary competitors on the market are tadalafil (Cialis) and vardenafil (Levitra).
Available Form:
Sildenafil Citrate Oral Films
We also offer Sustained (SR) / Immediate (IR) / Timed (TR) / Controlled (CR) / Delayed Release (DR) and Enteric Coated (EC).
Therapeutical:
Anti-erectile dysfunction Agent
Dosage:
Sildenafil citrate 100 mg
Solutions from us:
- Making process suitability for your products.
- Deciding the right kind of technology / equipments for the products.
- Process Validation & Stability.
- Documentation.
- Technology transfer of products with complete line of equipments.
- Doessair preparation.
- Validation and regulatory support.
| Sildenafil citrate Systematic (IUPAC) Name |
Sildenafil citrate Identifiers |
Sildenafil citrate Chemical data |
||||||||||||||||||||||
| 1-[4-ethoxy-3-(6,7-dihydro-1-methyl- 7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl) phenylsulfonyl]-4-methylpiperazine |
|
|
* All transactions are carried out in conformity with patent laws applicable in the user country. Active pharmaceutical ingredients or formulations thereof will not be supplied in countries where the same is under patent protection except as and if permitted under law of the country for research and development purposes only.